EUVIMEDEUVIMED entdecken
Crossref

Targeted muscle reinnervation for treatment of neuropathic pain in non-amputees – Indications and outcomes

Floris V Raasveld, Otis C van Varsseveld, Caroline A Hundepool, J Michiel Zuidam, Jonathan M Winograd, William G Austen, Ian L Valerio, Kyle R Eberlin

Journal of Plastic, Reconstructive & Aesthetic Surgery · 2025-06 · 105 · 359-368

DOI: 10.1016/j.bjps.2025.04.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2025-06. Verfasst von Floris V Raasveld und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic and Reconstructive Surgery, Department of General Surgery, Massachusetts General Hospital, Harvard University, Boston, MA, United…. Hauptthemen laut MEDLINE: Neuralgia, Muscle, Skeletal, Nerve Transfer. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Targeted Muscle Reinnervation (TMR) offers a promising surgical approach to prevent and treat neuropathic pain but has primarily been utilized in amputees. This study aims to describe indications and outcomes for TMR in non-amputees. METHODS: Non-amputee patients who underwent TMR for neuropathic pain at a tertiary center (2019-2024) were identified. Demographics, comorbidity, and surgical characteristics were collected through chart review. Patient satisfaction (Patient Global Impression of Change, PGIC) and quality of life (EQ-5D-5L) were assessed through a cross-sectional survey. RESULTS: Seventy-six TMR operations were performed in 74 patients (median age 54.5 (Interquartile range [IQR]: 42.0-65.0) years, 47.3% female). Thirty-four patients (44.7%) previously underwent other peripheral nerve surgery in the same nerve distribution before TMR surgery. Most TMR surgeries were performed in the lower extremity (n=52, 68.4%), followed by the trunk (n=15, 19.8%), upper extremity (n=6, 7.9%), and head/neck (n=3, 3.9%). Six patients (7.9%) underwent revision surgery to the nerve treated with TMR. Of 45 survey respondents (60.8%, mean follow-up 2.0±1.2 years), improvement (PGIC) was reported for 82.4% of lower extremity (n=28), 88.9% of trunk (n=8), and 50.0% of upper extremity (n=2) cases. Overall, 78.7% reported improvement (25.5% very much improved, 34.0% much improved, 19.2% minimally improved). Mean EQ-5D-5L indices were 0.828 (±0.082), 0.794 (±0.056), and 0.763 (±0.024) for lower extremity, trunk, and upper extremity, respectively, comparable to the US general population (0.851±0.205). CONCLUSIONS: Non-amputees report improvement in neuropathic pain across various anatomic regions, suggesting the benefit of TMR beyond the amputee population. LEVEL OF EVIDENCE: IV - Therapeutic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaMuscle, SkeletalNerve TransferHumansFemaleMaleMiddle AgedAdultAgedCross-Sectional StudiesQuality of LifePatient SatisfactionTreatment OutcomeRetrospective Studies

Stichwörter der Autor:innen

Neuropathic painNon-amputeesPROMsTargeted muscle reinnervation

Autor:innen und Institutionen

  • Division of Plastic and Reconstructive Surgery, Department of General Surgery, Massachusetts General Hospital, Harvard University, Boston, MA, United States; Hand and Arm Center, Department of Orthopaedic Surgery, Massa…
  • Hand and Arm Center, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States; Department of Surgery, University Medical Center Groningen, University of Gronin…
  • Department of Plastic, Reconstructive and Hand Surgery, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands.
  • Division of Plastic and Reconstructive Surgery, Department of General Surgery, Massachusetts General Hospital, Harvard University, Boston, MA, United States.
  • Division of Plastic and Reconstructive Surgery, Department of General Surgery, Massachusetts General Hospital, Harvard University, Boston, MA, United States. Electronic address: keberlin@mgh.harvard.edu.

Förderung

  • National Institutes of Health

Zitieren

APA

Raasveld, F. V., van Varsseveld, O. C., Hundepool, C. A., Zuidam, J. M., Winograd, J. M., Austen, W. G., Valerio, I. L., & Eberlin, K. R. (2025). Targeted muscle reinnervation for treatment of neuropathic pain in non-amputees – Indications and outcomes. Journal of Plastic, Reconstructive & Aesthetic Surgery, 105, 359-368. https://doi.org/10.1016/j.bjps.2025.04.026

Vancouver

Raasveld FV, van Varsseveld OC, Hundepool CA, Zuidam JM, Winograd JM, Austen WG, et al. Targeted muscle reinnervation for treatment of neuropathic pain in non-amputees – Indications and outcomes. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2025;105:359-368. doi:10.1016/j.bjps.2025.04.026

BibTeX
@article{Raasveld2025,
  author = {Raasveld, Floris V and van Varsseveld, Otis C and Hundepool, Caroline A and Zuidam, J Michiel and Winograd, Jonathan M and Austen, William G and Valerio, Ian L and Eberlin, Kyle R},
  title = {Targeted muscle reinnervation for treatment of neuropathic pain in non-amputees – Indications and outcomes},
  journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
  year = {2025},
  volume = {105},
  pages = {359--368},
  doi = {10.1016/j.bjps.2025.04.026}
}
Kostenlos starten →